Impact of neoadjuvant chemotherapy on breast reconstruction (pages 2833–2841)
Yue-Yung Hu, Christine M. Weeks, Haejin In, Christopher M. Dodgion, Mehra Golshan, Yoon S. Chun, Michael J. Hassett, Katherine A. Corso, Xiangmei Gu, Stuart R. Lipsitz and Caprice C. Greenberg
Article first published online: 24 JAN 2011 | DOI: 10.1002/cncr.25872
Cosmesis after mastectomy has assumed a pivotal role in patient and provider decision making, and multiple studies have confirmed the safety of both chemotherapy before breast surgery and immediate reconstruction. The current results indicated that administering neoadjuvant chemotherapy decreases the likelihood of undergoing immediate reconstruction but does not significantly increase the rate of delayed reconstruction.